Ikuti
Nimish Gera
Nimish Gera
Vice President, Biologics at Mythic Therapeutics
Email yang diverifikasi di ncsu.edu
Judul
Dikutip oleh
Dikutip oleh
Tahun
Protein selection using yeast surface display
N Gera, M Hussain, BM Rao
Methods 60 (1), 15-26, 2013
1632013
Highly stable binding proteins derived from the hyperthermophilic Sso7d scaffold
N Gera, M Hussain, RC Wright, BM Rao
Journal of Molecular Biology 409 (4), 601-616, 2011
1062011
Generation and properties of antibacterial coatings based on electrostatic attachment of silver nanoparticles to protein-coated polypropylene fibers
KK Goli, N Gera, X Liu, BM Rao, OJ Rojas, J Genzer
ACS Applied Materials and Interfaces, 2013
822013
Design of pH Sensitive Binding Proteins from the Hyperthermophilic Sso7d Scaffold
N Gera, AB Hill, DP White, RG Carbonell, BM Rao
PLOS ONE 7 (11), e48928, 2012
792012
Preservation of Cell Viability and Protein Conformation on Immobilization within Nanofibers via Electrospinning Functionalized Yeast
MF Canbolat, N Gera, C Tang, B Monian, BM Rao, B Pourdeyhimi, ...
ACS Applied Materials and Interfaces, 2013
452013
A nanophosphor‐based method for selective DNA recovery in Synthosomes
M Nallani, O Onaca, N Gera, K Hildenbrand, W Hoheisel, U Schwaneberg
Biotechnology journal 1 (7‐8), 828-834, 2006
362006
The evolution of bispecific antibodies
N Gera
Expert Opinion on Biological Therapy 22 (8), 945-949, 2022
282022
Growth Kinetics and Production of Glucose Oxidase Using Aspergillus niger NRRL 326
N Gera, RVS Uppaluri, S Sen, VV Dasu
Chemical and Biochemical Engineering Quarterly 22 (3), 315-320, 2008
192008
Biparatopic antibodies: therapeutic applications and prospects
DL Niquille, KM Fitzgerald, N Gera
mAbs 16 (1), 2310890, 2024
182024
Avidity‐mediated virus separation using a hyperthermophilic affinity ligand
M Hussain, D Lockney, R Wang, N Gera, BM Rao
Biotechnology Progress 29 (1), 237-246, 2013
122013
Scaffold diversification enhances effectiveness of a super-library of hyperthermophilic proteins
M Hussain, N Gera, AB Hill, BM Rao
ACS Synthetic Biology, 2012
102012
MYTX-011: A pH-Dependent Anti–c-MET Antibody–Drug Conjugate Designed for Enhanced Payload Delivery to c-MET–Expressing Tumor Cells
N Gera, KM Fitzgerald, V Ramesh, P Patel, D Kanojia, F Colombo, L Kien, ...
Molecular cancer therapeutics 23 (9), 1282-1293, 2024
72024
Characterization of the bispecific VHH antibody gefurulimab (ALXN1720) targeting complement component 5, and designed for low volume subcutaneous administration
S Jindal, DV Pedersen, N Gera, J Chandler, R Patel, A Neill, J Cone, ...
Molecular Immunology 165, 29-41, 2024
72024
MYTX-011: A novel cMET-targeting antibody drug conjugate (ADC) engineered to increase on-target uptake in and efficacy against cMET expressing tumors
N Gera, K Fitzgerald, V Ramesh, P Patel, L Kien, D Kanojia, S Aoyama, ...
Cancer Res. 83 (Suppl. 7)), 5000, 2023
52023
Yeast Display Guided Selection of pH-Dependent Binders
JN Meanor, AJ Keung, BM Rao, N Gera
Yeast Surface Display, 293-311, 2022
32022
Polypeptides that bind complement component C5 or serum albumin and fusion proteins thereof
B Puffer, J Chandler, N Gera, DL Sheridan, S Jindal, PP Tamburini
US Patent 11,498,960, 2022
22022
Polypeptides that bind complement component C5 or serum albumin and fusion proteins thereof
B Puffer, J Chandler, N Gera, DL Sheridan, S Jindal, PP Tamburini
US Patent 12,221,473, 2025
2025
ANTI-cMET ANTIBODY DRUG CONJUGATES AND THERAPEUTIC USES THEREOF
B Fiske, N Gera, W Comb, A Deshpande
US Patent App. 18/535,713, 2024
2024
Antigen-binding protein constructs and antibodies and uses thereof
AJ Nichols, BP Fiske, N Gera
US Patent App. 18/281,367, 2024
2024
Anti-met antibodies and uses thereof
BP Fiske, N Gera, AJ Nichols
US Patent App. 18/273,078, 2024
2024
Sistem tidak dapat melakukan operasi ini. Coba lagi nanti.
Artikel 1–20